MERIT MEDICAL SYSTEMS INC — Director's Dealing 2021

Sep 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-09-08

Reporting Person: Parra Raul Jr. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-08	Common Stock, No Par Value	M	2000	$44.8	Acquired	4343	Direct
2021-09-08	Common Stock, No Par Value	S	2000	$72.01	Disposed	2343	Direct
2021-09-09	Common Stock, No Par Value	M	2000	$44.80	Acquired	4343	Direct
2021-09-09	Common Stock, No Par Value	S	2000	$72	Disposed	2343	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-08	Non-qualified stock options (right to buy)	$44.80	M	2000	Disposed	2025-03-02	Common Stock (2000)	Direct
2021-09-09	Non-qualified stock options (right to buy)	$44.80	M	2000	Disposed	2025-03-02	Common Stock (2000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, No Par Value	2905.578	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified stock options (right to buy)	$28.20	2024-04-14	Common Stock (2000)	2000	Direct
Non-qualified stock options (right to buy)	$55.73	2026-03-01	Common Stock (30000)	30000	Direct
Non-qualified stock options (right to buy)	$37.71	2027-02-26	Common Stock (16722)	16722	Direct
Non-qualified stock options (right to buy)	$56.25	2028-03-19	Common Stock (9681)	9681	Direct

Footnotes

F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.03, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F2: Represents plan holdings as of 09/09/2021.

F3: Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.

F4: Becomes exercisable in equal annual installments of 20% commencing 04/14/2018.

F5: Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.

F6: Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.

F7: Becomes exercisable in equal annual installments of 25% commencing 03/19/2022.